menu
    • menu

    Company profile for Vipergen

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vipergen is a world leading provider of small molecule drug discovery services based on DNA-encoded library (DEL) technologies. Vipergen is finding tractable hits/leads for your pharmaceutical relevant targets, using three proprietary 2nd and 3rd generation DEL technologies. Vipergen is offering different business models, including simple Fee-For-Service. Vipergen is offering different business models, including simple Fee-F...
    Vipergen is a world leading provider of small molecule drug discovery services based on DNA-encoded library (DEL) technologies. Vipergen is finding tractable hits/leads for your pharmaceutical relevant targets, using three proprietary 2nd and 3rd generation DEL technologies. Vipergen is offering different business models, including simple Fee-For-Service. Vipergen is offering different business models, including simple Fee-For-Service. In 2015-20 >40 deals signed, including with top-5 pharma in both USA, EU and Japan. The company is privately owned by Gunnar Kjems and Dr. Nils Hansen incorporated in Copenhagen, Denmark

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VipergenDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Gammel Kongevej 23A, 1st floor DK-1610 Copenhagen
    Telephone
    Telephone
    +45 2523 6680
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vipergen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vipergen-aps/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurigene & Vipergen Partner to Co-Market & Offer DEL Screening to Customers
    Aurigene & Vipergen Partner to Co-Market & Offer DEL Screening to Customers

    19 Apr 2024

    // PRESS RELEASE

    https://www.aurigeneservices.com/sites/default/files/2024-04/APSL%20Vipergen%20Partnership_Media%20Note.pdf

    PRESS RELEASE
    19 Apr 2024
    Share Share
    Vipergen Establishes DEL-Based Drug Discovery Partnership with Theseus Pharma
    Vipergen Establishes DEL-Based Drug Discovery Partnership with Theseus Pharma

    04 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/vipergen-establishes-dna-encoded-library-del-based-drug-discovery-partnership-with-theseus-pharmaceuticals-focused-on-targeted-cancer-therapies-301516079.html

    PRNEWSWIRE
    04 Apr 2022
    Share Share
    Vipergen Partners with ALK Focused on DEL-Based Drug Discovery
    Vipergen Partners with ALK Focused on DEL-Based Drug Discovery

    15 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/vipergen-establishes-research-partnership-with-alk-focused-on-dna-encoded-library-del-based-drug-discovery-for-allergy-immunotherapies-301423632.html

    PRNEWSWIRE
    15 Nov 2021
    Share Share
    Vipergen Partners with PhoreMost on DNA Encoded Library Based Drug Discovery
    Vipergen Partners with PhoreMost on DNA Encoded Library Based Drug Discovery

    14 Sep 2021

    // PRNEWSWIRE

    prnewswire.com/news-releases/vipergen-establishes-research-partnership-with-phoremost-focused-on-dna-encoded-library-del-based-drug-discovery-301375915.html

    PRNEWSWIRE
    14 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search